Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVERT: Aprepitant + Ondansetron for Radiotherapy-Induced Nausea
NCT00970905Phase 2Completed
- Sponsor
- The University of Vermont
- Start
- Oct 2009
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aprepitant in nausea ((none)), Vomiting, sponsored by The University of Vermont. Started Oct 2009; status: completed.
02
Drugs
aprepitant
03
Conditions
nausea ((none))Vomiting
Beyond the preview
Go deeper on NCT00970905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00970905.